Latest News about LLY
Recent news which mentions LLY
Down 60%, Is This Growth Stock Too Cheap to Ignore?
April 22, 2025
From Motley Fool
Upcoming Pfizer Earnings Call Might Be Focused On Tariffs, Policy Risks And Obesity Pipeline
April 21, 2025
From Benzinga
ETFs Last Week: Thematic ETFs Gleamed Against Market Gloom
April 21, 2025
From Benzinga
Down 61%, Is Novo Nordisk Stock Worth Buying on the Dip?
April 21, 2025
From Motley Fool
US Stocks Likely To Open Lower: 'Best And Worst Days Tend To Occur Near The Same Time,' Says Expert
April 21, 2025
From Benzinga
Did Eli Lilly Just Say Checkmate to Novo Nordisk?
April 21, 2025
From Motley Fool
Dow Dips Over 500 Points, Down For 3rd Straight Session As UnitedHealth Tanks: Greed Index Remains In 'Extreme Fear' Zone
April 21, 2025
From Benzinga
In The Holiday Shortened Easter Week, These Large-Cap Stock Were Top Performers (Apr 14-Apr 18): Are These In Your Portfolio?
April 20, 2025
From Benzinga
Tickers
LLY
From Motley Fool
Benzinga Bulls And Bears: Netflix, UnitedHealth, Eli Lilly — And Market Volatility Continues
April 19, 2025
From Benzinga
Eli Lilly's Experimental Weight Loss Pill Succeeded in Its First Pivotal Trial. Is It Time to Buy?
April 19, 2025
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
April 18, 2025
From Benzinga
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot
April 18, 2025
From Benzinga
Where Will Eli Lilly Be in 5 Years?
April 18, 2025
From Motley Fool
Eli Lilly Rallies Over 14%, Notches Best Day Since June 2000 On Oral Weight-Loss Drug Results: Analysts React
April 17, 2025
From Benzinga
Novo Nordisk May Lag Behind Eli Lilly In Cardiometabolic Race, Analyst Downgrades Stock
April 17, 2025
From Benzinga
Wall Street Rebounds, Eli Lilly Rallies, UnitedHealth Group Plummets: What's Driving Markets Thursday?
April 17, 2025
From Benzinga
From Benzinga
Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide
April 17, 2025
From Motley Fool
From Benzinga
Eli Lilly's Oral GLP-1 Drug Orforglipron Hits Phase 3 Goals In Diabetes Trial, Stock Soars
April 17, 2025
From Benzinga
From Benzinga
Europe Approves Eisai-Biogen's Alzheimer's Drug 'Under Strict Conditions' After Initial Negative Opinion
April 16, 2025
From Benzinga
Skye Bioscience's Obesity Candidate Shows 30% Weight Loss When Combined With Eli Lilly's Blockbuster Drug In Animal Models
April 15, 2025
From Benzinga
Eli Lilly's Mounjaro Launch Triggers Weight-Loss Drug Craze In India, Novo Nordisk Seeks To Move Up Wegovy Launch
April 15, 2025
From Benzinga
Verve Therapeutics Touts Positive Data From Gene Editing Medicine To Lower Cholesterol After Single Dose
April 14, 2025
From Benzinga
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.